Effects of dienogest 0.5, 1, 2 and 3 mg/day on ovarian activity in healthy women.

Trial Profile

Effects of dienogest 0.5, 1, 2 and 3 mg/day on ovarian activity in healthy women.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Nov 2011

At a glance

  • Drugs Dienogest (Primary)
  • Indications Endometriosis; Menopausal syndrome; Pregnancy
  • Focus Pharmacodynamics
  • Most Recent Events

    • 29 Nov 2011 Results published in the Journal of Clinical Pharmacology.
    • 28 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top